| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b58f981963f6d55d627139e778c4ef7b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04 |
| filingDate |
1994-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41992055a10a3a487fdcc2eb3ad973f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c6f57e81bb19aa03580d7663e822c95 |
| publicationDate |
1995-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0678024-A1 |
| titleOfInvention |
Use of idazoxan and its derivatives in the treatment of alzheimer-type senility |
| abstract |
Use of a compound of general formula (I), wherein R is a hydrogen atom, a linear or branched C1-C4 alkyl radical or a linear or branched C1-C4 alkoxy radical, and its therapeutically acceptable salts, its racemic form or its optically active isomers. Said compound is useful in the preparation of a drug intended for use in the treatment of Alzheimer-type senility and pre-Alzheimer syndrome and the prevention of the progression of these diseases. |
| priorityDate |
1993-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |